See every side of every news story
Published loading...Updated

65 Equity Partners backs Cerbios-Pharma acquisition

Summary by Private Equity Wire
AS Healthcare Advanced Synthesis (HAS), backed by 65 Equity Partners, has acquired a stake in Cerbios-Pharma, a global manufacturer of chemical and biological active pharmaceutical ingredients (APIs), including those for antibody-drug conjugates (ADCs). Financial details of the transaction were not disclosed. Following the deal, 65 Equity Partners will hold around 40% of the combined entity, with the Braglia family maintaining majority ownership…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Private Equity Wire broke the news in on Tuesday, April 1, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.